查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1687912

药用玻璃包装：市场占有率分析、行业趋势和成长预测（2025-2030年）

Pharmaceutical Glass Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 159 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计 2025 年药用玻璃包装市场规模为 313.4 亿美元，到 2030 年将达到 405.6 亿美元，预测期内（2025-2030 年）的复合年增长率为 5.29%。

药用玻璃包装-市场-IMG1

关键亮点

  • 玻璃包装解决方案主要作为药品的初级包装，是製药业的关键包装材料之一。这主要是因为它永续、惰性、不渗透、可回收且品质不损失、可重复使用等优点。玻璃容器是製药业中具有重要应用的主要包装材料之一。
  • 全球製药业正在经历显着增长，对感染疾病和非感染疾病的治疗包装产生了需求。因此，药品生产对玻璃包装的需求日益增加，以保护药品免受损坏、生物污染和外界影响。
  • 此外，注射药物需求的不断增长也推动了製药业玻璃瓶的成长。预计癌症治疗和其他强效药物（如抗体结合物和速效类固醇）的强劲需求以及人均药品支出的增加将成为主要的成长动力。
  • 然而，玻璃包装面临挑战，因为原料价格和其他因素导致其昂贵，无法为大量消费的包装产品提供经济可行的解决方案。因此塑胶成为一种选择。
  • 新冠疫情导致药品需求维持稳定成长。疫情期间药品需求的激增对市场成长产生了正面影响。随着不同国家的製药商核准和逐步淘汰新药和疫苗，玻璃包装的应用范围不断扩大，预计玻璃包装将进一步成长。

药用玻璃包装市场趋势

新兴国家製药业推动成长

  • 新兴国家被描述为不断发展、繁荣的国家，儘管存在巨大风险，但有望提高投资回报率。儘管许多已开发国家的药品销售成长缓慢，但新兴市场的销售模式显示药品销售将持续扩张。多种经济和人口变数影响着新兴市场的趋势。例如，现有市场继续面临严峻形势，包括因专利到期导致的成长放缓、鼓励学名药替代的成本削减措施以及更严格的监管。
  • 药用玻璃包装产业在中国等国家已具有显着的渗透力。玻璃药品包装在已开发国家的应用越来越广泛。自从新冠疫情爆发以来，新兴国家的医疗保健和製药业一直在成长，为药用玻璃包装市场创造了机会。
  • 例如，2022年9月，肖特製药扩大了在中国的墨盒生产。中国和匈牙利正在投资数百万美元，以大幅提高药用墨盒的生产能力。
  • 此外，印度製药业高度重视研发。印度预计在 2022 年成为全球医疗保健强国，其研发生态系统不断扩大，药品出口不断增加，为国内各玻璃包装供应商创造机会。
  • 此外，东南亚和东亚的医药销售额预计将达到 2,630 亿美元，成为继北美和欧洲之后的第三大地区。这些成长要素，加上现有公司因行业成长而进行的投资，预计将推动市场成长。

亚太地区成长强劲

  • 中国多年来已建立了医药行业的标准体系，因此中国药用玻璃包装市场预计将快速成长。在国内，药品包装材料在保存期限内的稳定性以及使用过程中的安全性越来越受到重视。在此背景下，绿色、可降解、易使用的新型医药包装材料和容器蓬勃发展。
  • 由于大型跨国製药公司的存在，中国医疗保健市场规模庞大且成长迅速，这为玻璃包装市场带来了明显的机会。这些公司是中国医药市场最大的收益来源之一。
  • 在印度，由于医疗保健产业对非专利注射药物的使用日益增多，药用玻璃包装的需求也在增加。药用玻璃包装可容纳多种药物类型，包括注射剂和非注射剂。药用玻璃包装的关键属性是高化学耐久性，以最大限度地提高产品可靠性。
  • 印度在全球医药市场占有重要地位，随着市场规模的扩大，印度对玻璃包装的需求预计将会成长。根据印度品牌资产基金会网站发布的资料，印度是全球最大的学名药供应国，占全球供应量的20%，并满足全球60%以上的疫苗需求。据印度评级与研究公司称，预计2022年印度医药市场的收益将增加12%以上。
  • 此外，日本是继美国之后製药业发展最快的国家之一，并始终注重持续创新和专利药品。日本政府也透过放鬆对国际投资的管制促进了这一成长，从而推动了日本医药市场的发展。
  • 亚太其他地区包括印尼、澳洲、新加坡、泰国、韩国和马来西亚。推动市场发展的因素包括不断扩大的国际伙伴关係、生物相似药、不断增长的成品药出口以及强劲的学名药市场。

药用玻璃包装产业概况

药用玻璃包装市场较为分散。政府措施的不断增加以及对注射剂和其他药品的需求不断增长，为药用玻璃包装解决方案提供了丰厚的机会。整体来看，现有竞争对手之间的竞争十分激烈。大型公司正在各个医药产业积极扩张合併，推动市场需求。主要参与企业包括 Gerresheimer Glass Inc.、Corning Incorporated、Nipro Corporation、SGD SA 和 Stolzle-Oberglass GmbH。

  • 2022 年 9 月：Gerresheimer AG 和 StevanatoGroup SpA 基于 Stevanato Group 市场领先的 EZ-fill 技术开发了高端即用型 (RTU) 解决方案平台，最初专注于管瓶。预计客户将从此次伙伴关係中受益，包括提高生产力、提高品质标准、加快产品上市时间、降低整体拥有成本 (TCO) 和减少供应链风险。
  • 2022 年 7 月：医疗设备製造商 Nipro Corporation Japan 已投资 1 亿克罗埃西亚库纳（1,360 万美元/1,330 万欧元）在克罗埃西亚为製药业建造新的玻璃包装厂。 Nipro 的 Nipro PharmaPackaging 部门在萨格勒布郊外的运作开设了一家新工厂，生产用于包装救命药物的玻璃安瓿瓶和管瓶。

其他福利

  • Excel 格式的市场预测 (ME) 表
  • 3个月的分析师支持

目录

第一章 引言

  • 研究假设和市场定义
  • 研究范围

第二章调查方法

第三章执行摘要

第四章 市场洞察

  • 市场概览
  • 产业价值链分析
  • 产业吸引力-波特五力模型
    • 供应商的议价能力
    • 购买者和消费者的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争对手之间的竞争强度
  • COVID-19 工业影响评估

第五章市场动态

  • 市场驱动因素
    • 新兴国家製药业的成长
    • 提高可回收玻璃的商业价值
  • 市场限制
    • 替代材料的重要性日益增加

第六章市场区隔

  • 按产品
    • 瓶子
    • 管瓶
    • 安瓿
    • 药筒和注射器
    • 更多产品
  • 按地区
    • 北美洲
      • 美国
      • 加拿大
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 义大利
      • 其他欧洲国家
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 其他亚太地区
    • 拉丁美洲
      • 巴西
      • 阿根廷
      • 其他拉丁美洲
    • 中东和非洲
      • 沙乌地阿拉伯
      • 南非
      • 其他中东和非洲地区

第七章竞争格局

  • 公司简介
    • Gerresheimer AG
    • Corning Incorporated
    • Nipro Corporation
    • SGD SA（SGD PHARMA）
    • Stlzle-Oberglas GmBH（CAG Holding GmbH）
    • Bormioli Pharma SpA
    • West Pharmaceutical Services Inc.
    • Schott AG
    • Shandong Medicinal Glass Co. Ltd
    • Beatson Clark
    • Arab Pharmaceutical Glass Co.
    • Piramal Glass Private Limited（Piramal Group）
    • Sisecam Group

第八章投资分析

第九章 市场机会与未来趋势

简介目录
Product Code: 66844

The Pharmaceutical Glass Packaging Market size is estimated at USD 31.34 billion in 2025, and is expected to reach USD 40.56 billion by 2030, at a CAGR of 5.29% during the forecast period (2025-2030).

Pharmaceutical Glass Packaging - Market - IMG1

Key Highlights

  • Glass packaging solutions are offered mainly as the primary packaging for pharmaceutical products and are among the leading packaging materials for the pharmaceutical industry. This is primarily due to advantages such as being sustainable, inert, impermeable, recyclable with no loss in quality, and reusable. Glass containers are among the primary packaging materials that have found significant use in the pharmaceutical industries.
  • The pharmaceutical industry is growing significantly worldwide, creating the need for packaging for communicable and non-communicable disease treatments. Thus, the demand for glass packaging in pharmaceutical manufacturing is increasing as it protects medicines from damage, biological contamination, and external influences.
  • Furthermore, the growing demand for injectable pharmaceuticals is propelling the growth of glass bottles in the pharmaceutical industry. The strong demand for oncology and other high-potency drugs (such as antibody conjugates and steroids with a fast onset of action) and growth in the per capita pharmaceutical spending are expected to be the primary growth drivers.
  • Over time, the market also faced challenges that included glass packaging getting expensive due to raw material prices and other factors, and it could not provide economically viable solutions for packaging products across mass consumption. That marked the advent of plastics as an option.
  • The COVID-19 pandemic has left a steady growth rate with increased demand for medicines. The surge in the need for pharmaceutical drugs during the pandemic has positively impacted the market's growth. It is further expected to grow as new drugs and vaccines are being approved and phased out in different countries by pharmaceutical manufacturers, expanding the scope of glass packaging.

Pharmaceutical Glass Packaging Market Trends

Pharmaceutical Industry in Emerging Economies to Drive Growth

  • Emerging markets are described as growing prosperous nations where investment is anticipated to increase profits despite significant risks. While pharmaceutical sales grow slowly in many developed nations, emerging market sales patterns indicate ongoing expansion. Several economic and demographic variables influence the trend in these markets, such as challenging conditions in established markets, with growth that has been flattened due to patent expiration, cost-cutting measures that encourage generic replacement, and strict enforcement of restrictions.
  • The pharmaceutical glass packaging industry has seen significant penetration in nations like China. Glass pharmaceutical packaging is becoming more widely used in developed countries. After COVID-19, the healthcare and pharmaceutical sectors are growing in emerging nations, presenting opportunities for the pharmaceutical glass packaging market.
  • For instance, in September 2022, SCHOTT Pharma expanded cartridge output in China. Several million investments are intended to significantly improve the manufacturing capabilities for pharmaceutical cartridges in China and Hungary.
  • Moreover, R&D is highly valued in India's pharmaceutical sector. India became a worldwide medical giant in 2022 by enlarging its R&D ecosystem and raising pharmaceutical exports, creating opportunities for various domestic glass packaging vendors.
  • Furthermore, Southeast & East Asia is expected to generate USD 263 billion in pharmaceutical sales and take the third position after North America and Europe. All the growth factors and investments by significant market incumbents due to the industry's growth are anticipated to drive the market's growth.

Asia-Pacific to Witness Significant Growth

  • The Chinese pharmaceutical glass packaging market is expected to grow rapidly as China has built a standard system for the pharmaceutical industry over the years. The country pays more and more attention to the stability of pharmaceutical packaging materials during the drug storage period and safety when used. Against this background, new green, degradable, and easy-to-use pharmaceutical packaging materials and vessels are booming.
  • China's large and rapidly growing healthcare market has been an obvious target of opportunity for the glass packaging market due to the presence of major multinational pharmaceutical companies. These companies are among the most significant revenue earners in the Chinese pharmaceutical market.
  • In India, pharmaceutical glass packaging has been growing due to the increasing usage of generic injectable drugs in the healthcare industry. Pharmaceutical glass packaging is available in various drug types, such as injectable and non-injectable. The significant properties of pharmaceutical glass packaging include its high chemical durability, which maximizes the reliability of the products.
  • The demand for glass packaging in India is expected to proliferate as India is a prominent and expanding player in the global medicines market. According to data published on the India Brand Equity Foundation website, India is the world's largest provider of generic pharmaceuticals, accounting for 20% of the worldwide supply and meeting over 60% of global vaccine demand. According to India Ratings & Research, the Indian pharmaceutical market revenue was predicted to increase by more than 12% in 2022.
  • Furthermore, Japan has one of the fastest-growing pharmaceutical industries after the United States and constantly focuses on steady innovation and patented drugs. The Government of Japan also contributes to this growth through deregulations for international companies to invest, thereby driving the country's pharmaceutical market.
  • The scope of the Rest of the Asia-Pacific region covers Indonesia, Australia, Singapore, Thailand, South Korea, and Malaysia. The market is driven by the growth in international partnerships, biosimilars, the expansion in the export of finished formulations, and a robust generics market.

Pharmaceutical Glass Packaging Industry Overview

The pharmaceutical glass packaging market is fragmented. The surge in government initiatives and increasing demand for injectables and other medicines provide lucrative pharmaceutical glass packaging solutions opportunities. Overall, the competitive rivalry among existing competitors is high. Large companies are actively involved in expansion and mergers in different pharmaceutical industries, driving the demand in the market. Key players include Gerresheimer Glass Inc., Corning Incorporated, Nipro Corporation, SGD SA, and Stolzle-Oberglass GmbH.

  • September 2022: Gerresheimer AG and StevanatoGroup SpA developed a high-end ready-to-use (RTU) solution platform with an initial focus on vials built on Stevanato Group's market-leading EZ-fill technology. The customers are expected to benefit from the partnership in terms of increased productivity, higher quality standards, quicker time to market, lower total cost of ownership (TCO), and reduced supply chain risk.
  • July 2022: Nipro Corporation Japan, a medical equipment manufacturing company, invested HRK 100 million (USD 13.6 million/EUR 13.3 million) in a new glass packaging plant for the pharmaceutical industry in Croatia. The new factory that produces glass ampoules and vials to package life-saving drugs was inaugurated in Zagreb's suburb Sesvete, Nipro's division, Nipro PharmaPackaging.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Value Chain Analysis
  • 4.3 Industry Attractiveness - Porter Five Forces
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Buyers/Consumers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitutes
    • 4.3.5 Intensity of Competitive Rivalry
  • 4.4 Assessment of COVID-19 Impact on the Industry

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Growth of Pharmaceutical Industry in Emerging Economies
    • 5.1.2 Commodity Value of Glass Increased with Recyclability
  • 5.2 Market Restraints
    • 5.2.1 Increased Relevance of Alternate Material

6 MARKET SEGMENTATION

  • 6.1 By Product
    • 6.1.1 Bottles
    • 6.1.2 Vials
    • 6.1.3 Ampoules
    • 6.1.4 Cartridges and Syringes
    • 6.1.5 Others Products
  • 6.2 By Geography
    • 6.2.1 North America
      • 6.2.1.1 United States
      • 6.2.1.2 Canada
    • 6.2.2 Europe
      • 6.2.2.1 Germany
      • 6.2.2.2 United Kingdom
      • 6.2.2.3 France
      • 6.2.2.4 Italy
      • 6.2.2.5 Rest of Europe
    • 6.2.3 Asia-Pacific
      • 6.2.3.1 China
      • 6.2.3.2 India
      • 6.2.3.3 Japan
      • 6.2.3.4 Rest of Asia-Pacific
    • 6.2.4 Latin America
      • 6.2.4.1 Brazil
      • 6.2.4.2 Argentina
      • 6.2.4.3 Rest of Latin America
    • 6.2.5 Middle East and Africa
      • 6.2.5.1 Saudi Arabia
      • 6.2.5.2 South Africa
      • 6.2.5.3 Rest of Middle East and Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Gerresheimer AG
    • 7.1.2 Corning Incorporated
    • 7.1.3 Nipro Corporation
    • 7.1.4 SGD SA (SGD PHARMA)
    • 7.1.5 Stlzle-Oberglas GmBH (CAG Holding GmbH)
    • 7.1.6 Bormioli Pharma SpA
    • 7.1.7 West Pharmaceutical Services Inc.
    • 7.1.8 Schott AG
    • 7.1.9 Shandong Medicinal Glass Co. Ltd
    • 7.1.10 Beatson Clark
    • 7.1.11 Arab Pharmaceutical Glass Co.
    • 7.1.12 Piramal Glass Private Limited (Piramal Group)
    • 7.1.13 Sisecam Group

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS